First Page | Document Content | |
---|---|---|
![]() Date: 2016-07-02 14:50:25Health Medicine Breakthrough therapy Specialty drugs Gilead Sciences Healthcare-associated infections Cyclopropanes Sofosbuvir Ledipasvir National Institute for Health and Care Excellence Hepatitis National Health Service | Add to Reading List |
![]() | California Schools VEBA Important Benefit Update Attention Member IMPORTANT: If you have not received your Welcome Kit with your ID cards, pleaseDocID: 1rr76 - View Document |
![]() | Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar NoDocID: 1rqYi - View Document |
![]() | February 2016 Rx Price Watch ReportDocID: 1rosR - View Document |
![]() | présenteit - mediA - phA rmADocID: 1riP0 - View Document |
![]() | PDF DocumentDocID: 1ri6p - View Document |